The Efficacy and Safety of SBRT in MPLC Clinical Trial
To Evaluate the Effectiveness and Safety of Stereotactic Radiotherapy (SBRT) in the Treatment of Patients With Residual Malignant Pulmonary Nodules After Lung Cancer Surgery: A Multi-center, Prospective Clinical Trial
To prospectively evaluate the effectiveness and safety of SBRT in the treatment of residual malignant pulmonary nodules after lung cancer, and is committed to providing new treatment options for patients with multiple primary malignant pulmonary nodules who cannot tolerate multiple operations.
|Study type||Observational [Patient Registry]|
|Source||Second Xiangya Hospital of Central South University|
|Contact||Chunhong Hu, professor|
|Start date||September 15, 2021|
|Completion date||September 14, 2024|